Esperion Therapeutics
Eric Warren joined Esperion as Vice President, US Sales, and Marketing in January 2021 and became Chief Commercial Officer in March 2022. He has extensive marketing and sales leadership experience, with 25 years in the pharmaceutical industry. Over that time, Eric has developed a breadth of clinical and commercial expertise, focusing primarily on cardio-metabolic and acute care medicine.
Prior to joining Esperion, Eric was Vice President, Head of Sales and Marketing at Nabriva Therapeutics, and also held Vice President roles at Sanofi. In all of these roles, Eric made it his mission to unify sales and marketing teams to enable rapid patient adoption. Eric also spent several years at Merck & Co. in various sales and marketing leadership roles.
Eric holds a Bachelor of Science in Pharmacy and is a licensed pharmacist in New York State.
This person is not in any offices
Esperion Therapeutics
2 followers
Through scientific and clinical excellence, and a deep understanding of cholesterol biology, the experienced Lipid Management Team at ESPERION is committed to developing new LDL-C lowering medicines that will make a substantial impact on reducing global cardiovascular disease, the leading cause of death around the world.